Literature DB >> 9741833

A distal regulatory region of the insulin-like growth factor binding protein-2 (IGFBP-2) gene interacts with the basic helix-loop-helix transcription factor, AP-4.

L Badinga1, S Song, R C Simmen, F A Simmen.   

Abstract

Insulin-like growth factor binding protein-2 (IGFBP-2), the predominant IGFBP in the fetal circulation and an induced protein during several types of malignancies, belongs to a family of structurally related proteins that bind the mitogens, IGF-1 and IGF-2. The present study focused on functional analysis of the 5 '-flanking region (approximately 1.3 kb) of the IGFBP-2 gene to identify nuclear factors that mediate hepatic transcription of this gene. Luciferase (LUC) reporter constructs containing progressive deletions of 5'-flanking DNA and the intact promoter of the porcine IGFBP-2 gene were examined for functional activity by transient transfection of human HepG2 liver cells. LUC activity of the transfected reporter gene driven by the IGFBP-2 promoter and flanking sequences to -1397 (numbering relative to initiation codon at +1) was 22-fold higher than that of promoterless parent LUC vector. This activity was decreased by 60% with deletion of sequences to -874 bp, and dropped to basal levels with further truncation to -764 bp. The region between -874 and -765 bp (110 bp) functioned as a potent stimulator of heterologous SV40 promoter activity (110 bp/SV40-LUC construct) and was found to contain two noncontiguous basic helix-loop-helix (bHLH) transcription factor binding motifs (E-boxes [CAN NTG]: CACCTG and CAAATG). In electrophoretic mobility shift assays, nuclear proteins prepared from HepG2 cells formed two complexes (C1, C2) with double-stranded oligonucleotides containing either HLH sequence, mutations of which resulted in loss of complex formation. Southwestern blot analysis identified an HepG2 nuclear protein with molecular mass of 48 kDa, similar to that of the bHLH transcription factor AP-4, which bound the CACCTG motif. Cotransfection of HepG2 cells with the 110-bp/SV40-LUC construct and an expression vector encoding human AP-4 increased IGFBP-2 fragment-dependent SV40 promoter activity by 16-fold. This AP-4-mediated stimulation was lost following block mutation of both bHLH motifs within the IGFBP-2 110-bp fragment. Results demonstrate the functional importance of sequences upstream of the promoter in IGFBP-2 gene transcription and identify a novel mechanism by which bHLH proteins potentially may affect cell proliferation and differentiation via induction of IGFBP-2 synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741833     DOI: 10.1385/ENDO:8:3:281

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  41 in total

1.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

2.  The expression pattern of an insulin-like growth factor (IGF)-binding protein gene is distinct from IGF-II in the midgestational rat embryo.

Authors:  T L Wood; A L Brown; M M Rechler; J E Pintar
Journal:  Mol Endocrinol       Date:  1990-08

3.  The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats.

Authors:  L Y Tseng; A L Brown; Y W Yang; J A Romanus; C C Orlowski; T Taylor; M M Rechler
Journal:  Mol Endocrinol       Date:  1989-10

4.  Regulation of hepatic expression of IGF I and fetal IGF binding protein mRNA in streptozotocin-diabetic rats.

Authors:  M Böni-Schnetzler; K Binz; J L Mary; C Schmid; J Schwander; E R Froesch
Journal:  FEBS Lett       Date:  1989-07-17       Impact factor: 4.124

5.  Cloning and characterization of the gene encoding murine insulin-like growth factor-binding protein-2, mIGFBP-2.

Authors:  J Landwehr; K Kaupmann; G Heinrich; J Schwander
Journal:  Gene       Date:  1993-02-28       Impact factor: 3.688

6.  Multiple upstream promoter elements of the gene for the pregnancy-associated tartrate-resistant acid phosphatase, uteroferrin bind human endometrial nuclear proteins.

Authors:  B Y Gonzalez; O P Perera; F J Michel; R C Simmen
Journal:  Mol Cell Endocrinol       Date:  1995-02-27       Impact factor: 4.102

7.  Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer.

Authors:  A Karasik; J Menczer; C Pariente; H Kanety
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

8.  Structure of the human insulin-like growth factor binding protein-2 gene.

Authors:  C Binkert; J B Margot; J Landwehr; G Heinrich; J Schwander
Journal:  Mol Endocrinol       Date:  1992-05

9.  Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro.

Authors:  N Mermod; T J Williams; R Tjian
Journal:  Nature       Date:  1988-04-07       Impact factor: 49.962

10.  Chromosomal organization of the gene encoding porcine antileukoproteinase and functional analysis of the promoter region in endometrial and placental cells.

Authors:  R C Simmen; L Badinga; F J Michel
Journal:  Mol Cell Endocrinol       Date:  1993-11       Impact factor: 4.102

View more
  10 in total

1.  AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.

Authors:  Shaopeng Chen; Sung-Kay Chiu
Journal:  Mol Cell Biochem       Date:  2015-06-03       Impact factor: 3.396

2.  Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells.

Authors:  Yiping Wang; Xiangdong Cheng; Muhammad Kaleem Samma; Sam K P Kung; Clement M Lee; Sung Kay Chiu
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

3.  The members of bHLH transcription factor superfamily are required for female reproduction in the red flour beetle, Tribolium castaneum.

Authors:  Kavita Bitra; Subba R Palli
Journal:  J Insect Physiol       Date:  2010-03-16       Impact factor: 2.354

4.  Transcription factor AP-4 is a ligand for immunoglobulin-kappa promoter E-box elements.

Authors:  A Aranburu; R Carlsson; C Persson; T Leanderson
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

5.  Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.

Authors:  Wei-Chi Ku; Sung-Kay Chiu; Yi-Ju Chen; Hsin-Hung Huang; Wen-Guey Wu; Yu-Ju Chen
Journal:  Mol Cell Proteomics       Date:  2009-06-07       Impact factor: 5.911

6.  Alpha TC1 and Beta-TC-6 genomic profiling uncovers both shared and distinct transcriptional regulatory features with their primary islet counterparts.

Authors:  Nathan Lawlor; Ahrim Youn; Romy Kursawe; Duygu Ucar; Michael L Stitzel
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

Review 7.  Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance.

Authors:  Hatim Boughanem; Elena M Yubero-Serrano; José López-Miranda; Francisco J Tinahones; Manuel Macias-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

Review 8.  Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die.

Authors:  Matthew Man-Kin Wong; Sancy Mary Joyson; Heiko Hermeking; Sung Kay Chiu
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

9.  Comparative Genomic Characterization of Insulin-Like Growth Factor Binding Proteins in Cattle and Buffalo.

Authors:  Muhammad Saif-Ur Rehman; Muqeet Mushtaq; Faiz-Ul Hassan; Muhammad Mushahid; Borhan Shokrollahi
Journal:  Biomed Res Int       Date:  2022-07-25       Impact factor: 3.246

Review 10.  Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates.

Authors:  Andreas Hoeflich; Elisa Wirthgen; Robert David; Carl Friedrich Classen; Marion Spitschak; Julia Brenmoehl
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-07       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.